3D Cell Culture Market worth US$2.26 billion by 2030 with 11.7% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Oct. 6, 2025 /PRNewswire/ -- The global 3D Cell Culture Market, valued at US$1.18 billion in 2024, stood at US$1.29 billion in 2025 and is projected to advance at a resilient CAGR of 11.7% from 2025 to 2030, culminating in a forecasted valuation of US$2.26 billion by the end of the period. The growth of this market is mainly driven by the increasing adoption of 3D cell culture over 2D cell culture and the rising demand for personalized medicine across the globe. Furthermore, the emergence of microfluidics-based 3D cell culture is likely to boost market growth in the coming years.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847
Browse in-depth TOC on " 3D Cell Culture Market "
205 - Tables
39 - Figures
244 - Pages
By product, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. Scaffold-based 3D cell cultures dominated the market, with the highest share in 2024. Scaffold-based 3D cell culture is a promising new technology used for a variety of applications, including drug discovery, tissue engineering, and regenerative medicine. Increased adoption of this technology across various industries is likely to have a positive influence on market growth.
By end users, the 3D cell culture market is segmented into pharmaceutical & biotechnology companies, research institutes, the cosmetics industry, and other end users. Pharmaceutical & biotechnology companies accounted for the largest share of the 3D cell culture market in 2024. Increase in demand for 3D cell culture in the development of various drug candidates is the key contributor to the segment's dominance.
By region, the 3D cell culture market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America accounted for the largest share of the 3D cell culture market. This leadership is driven by the region's high healthcare expenditure and substantial investments in life sciences research, enabling rapid adoption of advanced culture technologies. The strong presence of pharmaceutical and biotechnology companies' fuels demand for 3D models in drug discovery, toxicology studies, and personalized medicine. Regulatory and funding support from organizations such as the National Institutes of Health (NIH) further accelerates the transition from 2D to physiologically relevant 3D systems. Key players, including Thermo Fisher Scientific Inc. (US), Corning Incorporated (US), and Avantor Inc. (US), have a strong regional presence, ensuring innovation and commercialization of advanced culture platforms. Prominent academic institutions, such as Harvard University (US) and Massachusetts Institute of Technology (US), act as pioneers in validating and scaling emerging 3D applications. In addition, a favorable funding and collaboration environment supports adoption across hospitals, biotech firms, and research centers, reinforcing North America's dominant position in the global market.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=191072847
The 3D cell culture market is consolidated. The prominent players operating in this market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), Tecan Trading AG (Switzerland), Avantor, Inc. (US), and REPROCELL Inc. (Japan), among others. The key players of this market are mostly focusing on collaborations, acquisitions, partnerships, agreements, expansion, and advancements in 3D cell culture technology.
Thermo Fisher Scientific Inc. (US)
Thermo Fisher Scientific Inc. remains a key player in the 3D cell culture market in 2024, supported by its comprehensive and diversified product portfolio, broad geographic presence, and balanced focus on organic and inorganic growth strategies. In 2024, the company expanded its portfolio by launching advanced 3D cell culture solutions to enhance cancer and stem cell research applications. Thermo Fisher continues to prioritize innovation through significant investments in research and development, ensuring the delivery of cutting-edge technologies that align with the evolving demands of the scientific community. The company's robust global distribution network further strengthens product accessibility and customer engagement, enabling the company to deliver reliable and scalable 3D cell culture solutions. This integrated strategic approach reinforces Thermo Fisher's leadership in the 3D cell culture landscape.
Merck KGaA (Germany)
Merck KGaA stands out as a leading player in the 3D cell culture market in 2024, demonstrating a strong commitment to research and development, dedicating significant resources to innovation to advance 3D cell culture applications across research and biopharmaceutical development. Merck's extensive global distribution network further strengthens accessibility and customer support, enabling the delivery of reliable and high-quality 3D cell culture solutions. This multifaceted approach firmly positions Merck as a key provider in the 3D cell culture landscape. With its strong R&D capabilities and product portfolio, the company is expected to maintain its leading position in the market.
For more information, Inquire Now!
Related Reports:
Get access to the latest updates on 3D Cell Culture Companies and 3D Cell Culture Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
Share this article